procaterol has been researched along with Cancer of Prostate in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Cai, Q | 1 |
| Wang, J | 1 |
| Yao, Z | 1 |
| Ji, F | 1 |
| Hang, Y | 1 |
| Ma, J | 1 |
| Jiang, H | 1 |
| Yan, B | 1 |
| Zhanghuang, C | 1 |
1 trial available for procaterol and Cancer of Prostate
| Article | Year |
|---|---|
Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
Topics: Aged; Calibration; Databases, Factual; Humans; Male; Nomograms; Procaterol; Prostatic Neoplasms; Rep | 2023 |